These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 34611971)

  • 1. Idiopathic pulmonary fibrosis: Physician and patient perspectives on the pathway to care from symptom recognition to diagnosis and disease burden.
    Lancaster L; Bonella F; Inoue Y; Cottin V; Siddall J; Small M; Langley J
    Respirology; 2022 Jan; 27(1):66-75. PubMed ID: 34611971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physician- and patient-reported perspectives on myasthenia gravis in Europe: a real-world survey.
    Mahic M; Bozorg A; DeCourcy J; Golden K; Gibson G; Taylor C; Scowcroft A
    Orphanet J Rare Dis; 2023 Jun; 18(1):169. PubMed ID: 37386469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physician- and Patient-Reported Severity and Quality of Life Impact of Alopecia Areata: Results from a Real-World Survey in Five European Countries.
    Vañó-Galván S; Blume-Peytavi U; Farrant P; Reygagne P; Johansson E; Reed C; Marwaha S; Durand F; Piraccini BM
    Dermatol Ther (Heidelb); 2023 Dec; 13(12):3121-3135. PubMed ID: 37889388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of Life and Healthcare Resource Use in a Real-world Patient Population with Idiopathic Pulmonary Fibrosis: The PROOF Registry.
    Wuyts WA; Dahlqvist C; Slabbynck H; Schlesser M; Gusbin N; Compere C; Maddens S; Rizzo S; Kirchgaessler KU; Bartley K; Bondue B
    Pulm Ther; 2022 Jun; 8(2):181-194. PubMed ID: 35429319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology, healthcare utilization, and related costs among patients with IPF: results from a German claims database analysis.
    Kreuter M; Picker N; Schwarzkopf L; Baumann S; Cerani A; Postema R; Maywald U; Dittmar A; Langley J; Patel H
    Respir Res; 2022 Mar; 23(1):62. PubMed ID: 35305632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unmet needs in the treatment of idiopathic pulmonary fibrosis-insights from patient chart review in five European countries.
    Maher TM; Molina-Molina M; Russell AM; Bonella F; Jouneau S; Ripamonti E; Axmann J; Vancheri C
    BMC Pulm Med; 2017 Sep; 17(1):124. PubMed ID: 28915874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethnographic survey of patients and caregiver's life journey in idiopathic pulmonary fibrosis.
    Ahmed L; Bergot E; Prévot G; Cottin V
    Respir Med Res; 2023 Jun; 83():100955. PubMed ID: 36634553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Idiopathic Pulmonary Fibrosis on Longitudinal Health-care Utilization in a Community-Based Cohort of Patients.
    Farrand E; Iribarren C; Vittinghoff E; Levine-Hall T; Ley B; Minowada G; Collard HR
    Chest; 2021 Jan; 159(1):219-227. PubMed ID: 32717266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying Barriers to Idiopathic Pulmonary Fibrosis Treatment: A Survey of Patient and Physician Views.
    Maher TM; Swigris JJ; Kreuter M; Wijsenbeek M; Cassidy N; Ireland L; Axmann J; Nathan SD
    Respiration; 2018; 96(6):514-524. PubMed ID: 30114692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic Likelihood Thresholds That Define a Working Diagnosis of Idiopathic Pulmonary Fibrosis.
    Walsh SLF; Lederer DJ; Ryerson CJ; Kolb M; Maher TM; Nusser R; Poletti V; Richeldi L; Vancheri C; Wilsher ML; Antoniou KM; Behr J; Bendstrup E; Brown KK; Corte TJ; Cottin V; Crestani B; Flaherty KR; Glaspole IN; Grutters J; Inoue Y; Kondoh Y; Kreuter M; Johannson KA; Ley B; Martinez FJ; Molina-Molina M; Morais A; Nunes H; Raghu G; Selman M; Spagnolo P; Taniguchi H; Tomassetti S; Valeyre D; Wijsenbeek M; Wuyts WA; Wells AU
    Am J Respir Crit Care Med; 2019 Nov; 200(9):1146-1153. PubMed ID: 31241357
    [No Abstract]   [Full Text] [Related]  

  • 11. Idiopathic Pulmonary Fibrosis: Utilization of Health Services and Out-Of-Pocket Health Expenditures in Greece.
    Naoum P; Athanasakis K; Skroumpelos A; Kyriopoulos J
    Value Health Reg Issues; 2020 Sep; 22():44-48. PubMed ID: 32777730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Healthcare resource utilization and quality of life by cognitive impairment in patients with schizophrenia.
    Kadakia A; Fan Q; Shepherd J; Dembek C; Bailey H; Walker C; Williams GR
    Schizophr Res Cogn; 2022 Jun; 28():100233. PubMed ID: 35004189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Qualitative European survey of patients with idiopathic pulmonary fibrosis: patients' perspectives of the disease and treatment.
    Russell AM; Ripamonti E; Vancheri C
    BMC Pulm Med; 2016 Jan; 16():10. PubMed ID: 26762154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health Care Costs at the End of Life for Patients with Idiopathic Pulmonary Fibrosis. Evaluation of a Pilot Multidisciplinary Collaborative Interstitial Lung Disease Clinic.
    Kalluri M; Lu-Song J; Younus S; Nabipoor M; Richman-Eisenstat J; Ohinmaa A; Bakal JA
    Ann Am Thorac Soc; 2020 Jun; 17(6):706-713. PubMed ID: 32197048
    [No Abstract]   [Full Text] [Related]  

  • 15. Characteristics, clinical outcomes and patient-reported outcomes of patients with ulcerative colitis receiving tofacitinib: a real-world survey in the United States and five European countries.
    Armuzzi A; Hart A; Cappelleri JC; Mammar N; Hur P; Hoskin B; Hennessy F; Milligan G; Dignass A
    BMC Gastroenterol; 2023 Jan; 23(1):17. PubMed ID: 36658481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient confidence and quality of life in idiopathic pulmonary fibrosis and sarcoidosis.
    Kotecha J; Atkins C; Wilson A
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Dec; 33(4):341-348. PubMed ID: 28079846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiopathic pulmonary fibrosis: Educational needs of health-care providers, patients, and caregivers.
    Ramadurai D; Corder S; Churney T; Graney B; Harshman A; Meadows S; Swigris JJ
    Chron Respir Dis; 2019; 16():1479973119858961. PubMed ID: 31288534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive fibrosing interstitial lung diseases: current practice in diagnosis and management.
    Wijsenbeek M; Kreuter M; Olson A; Fischer A; Bendstrup E; Wells CD; Denton CP; Mounir B; Zouad-Lejour L; Quaresma M; Cottin V
    Curr Med Res Opin; 2019 Nov; 35(11):2015-2024. PubMed ID: 31328965
    [No Abstract]   [Full Text] [Related]  

  • 19. The Burden of Progressive Fibrosing Interstitial Lung Disease: A DELPHI Approach.
    Wuyts WA; Papiris S; Manali E; Kilpeläinen M; Davidsen JR; Miedema J; Robalo-Cordeiro C; Morais A; Artés M; Asijee G; Cendoya D; Soulard S
    Adv Ther; 2020 Jul; 37(7):3246-3264. PubMed ID: 32445186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of a disease-management program on symptom burden and health-related quality of life in patients with idiopathic pulmonary fibrosis and their care partners.
    Lindell KO; Olshansky E; Song MK; Zullo TG; Gibson KF; Kaminski N; Hoffman LA
    Heart Lung; 2010; 39(4):304-13. PubMed ID: 20561836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.